479 related articles for article (PubMed ID: 19666756)
1. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction.
Greenhill SR; Kotton DN
Chest; 2009 Aug; 136(2):571-577. PubMed ID: 19666756
[TBL] [Abstract][Full Text] [Related]
2. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.
Bonfield TL; Raychaudhuri B; Malur A; Abraham S; Trapnell BC; Kavuru MS; Thomassen MJ
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1132-6. PubMed ID: 12896880
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
5. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
Seymour JF
Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
[TBL] [Abstract][Full Text] [Related]
6. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
[TBL] [Abstract][Full Text] [Related]
7. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
[TBL] [Abstract][Full Text] [Related]
8. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis.
Tchou-Wong KM; Harkin TJ; Chi C; Bodkin M; Rom WN
Am J Respir Crit Care Med; 1997 Dec; 156(6):1999-2002. PubMed ID: 9412586
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice.
Reed JA; Ikegami M; Cianciolo ER; Lu W; Cho PS; Hull W; Jobe AH; Whitsett JA
Am J Physiol; 1999 Apr; 276(4):L556-63. PubMed ID: 10198353
[TBL] [Abstract][Full Text] [Related]
11. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
Ito M; Nakagome K; Ohta H; Akasaka K; Uchida Y; Hashimoto A; Shiono A; Takada T; Nagata M; Tohyama J; Hagiwara K; Kanazawa M; Nakata K; Tazawa R
BMC Pulm Med; 2017 Feb; 17(1):40. PubMed ID: 28212655
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary alveolar proteinosis].
Floarea-Strat A; Stanciu A; Creţeanu M
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):518-23. PubMed ID: 14756054
[TBL] [Abstract][Full Text] [Related]
13. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis.
Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR
Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary alveolar proteinosis: time to shift?
Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
[TBL] [Abstract][Full Text] [Related]
15. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
16. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
18. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.
Dalrymple H; Barna BP; Malur A; Malur AG; Kavuru MS; Thomassen MJ
BMC Immunol; 2013 Sep; 14():41. PubMed ID: 24044676
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.
Ferretti A; Fortwendel JR; Gebb SA; Barrington RA
J Immunol; 2016 Jul; 197(2):470-9. PubMed ID: 27279372
[TBL] [Abstract][Full Text] [Related]
20. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
